Improvement of an l-Leucine-Producing Mutant of Brevibacterium lactofermentum 2256 by Genetically Desensitizing It to alpha-Acetohydroxy Acid Synthetase.
Genetic improvement of l-leucine productivity in strain 218, an ile 2-thiazolealanine-resistant mutant of Brevibacterium lactofermentum 2256, was attempted. In strain 218, which produced 28 mg of l-leucine per ml from 13% glucose, alpha-isopropylmalate synthetase was genetically desensitized and derepressed to the effect of l-leucine, whereas alpha-acetohydroxy acid synthetase remained unaltered, although it could be derepressed phenotypically by limiting the isoleucine concentration in the culture. From strain 218 we isolated 103 mutants resistant to beta-hydroxyleucine (4 mg/ml). Among these, three were found to produce mere l-leucine than the parent. The alpha-acetohydroxy acid synthetase of all three mutant strains was found to be genetically desensitized to all of the branched-chain amino acids l-isoleucine, l-valine, and l-leucine. The repression mechanism in alpha-acetohydroxy acid synthetase formation was the same as in the parent strain. The improved strains typically produced 34 mg of l-leucine per ml, the highest productivity ever reported.
Tsuchida
T
T
Central Research Laboratories, Ajinomoto Co., Inc., Kawasaki 210, Japan.
Momose
H
H